“Often when people think of neurodegeneration, they focus on the end of the process, which is characterized by neuron death. But in fact, neurodegeneration is a long and complex process across a broad range of neurodegenerative diseases, with synaptic dysfunction and deterioration taking place long before neuronal cell loss. In animal models, CervoMed and others have shown that if you treat synaptic dysfunction at the early stages of disease, you’re able to restore synaptic function and avert neuron death, giving us new hope and optimism for treating dementia with Lewy bodies and other neurological disorders.”

John Alam, MD, CervoMed Founder and CEO